These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2441635)

  • 21. [Treatment of chronic active hepatitis caused by hepatitis B virus infection].
    Degos F; Marcellin P; Benhamou JP
    Gastroenterol Clin Biol; 1988 Nov; 12(11):845-54. PubMed ID: 2464521
    [No Abstract]   [Full Text] [Related]  

  • 22. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.
    Novick DM; Lok AS; Thomas HC
    J Hepatol; 1985; 1(1):29-35. PubMed ID: 2414358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral hepatitis: towards the eradication of HCV and a cure for HBV.
    Asselah T; Marcellin P
    Liver Int; 2015 Jan; 35 Suppl 1():1-3. PubMed ID: 25529080
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of adenine-arabinosine with glycyrrhizin in treating chronic active hepatitis].
    Zhang ZH; Yang ZH
    Zhong Xi Yi Jie He Za Zhi; 1988 Mar; 8(3):150-1, 157, 132-3. PubMed ID: 3416396
    [No Abstract]   [Full Text] [Related]  

  • 25. [Reappraisal of different therapeutic strategies for combating hepatitis B].
    Si CW
    Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):363-4. PubMed ID: 14509982
    [No Abstract]   [Full Text] [Related]  

  • 26. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.
    Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M
    Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological and anti-viral therapy of chronic hepatitis B virus infection.
    Thomas HC; Bassendine MF
    Clin Gastroenterol; 1980 Jan; 9(1):85-95. PubMed ID: 6156790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral treatment in chronic infection with hepatitis B virus.
    Alexander G; Williams R
    Br Med J (Clin Res Ed); 1986 Apr; 292(6525):915-7. PubMed ID: 2421818
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of chronic hepatitis due to hepatitis B virus.
    Sherlock S; Thomas HC
    Lancet; 1985 Dec; 2(8468):1343-6. PubMed ID: 2866396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Navigating the maze of hepatitis B treatments.
    Lok AS
    Gastroenterology; 2007 Apr; 132(4):1586-94. PubMed ID: 17408643
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vidarabine-interferon combination in patients with chronic viral hepatitis B of mutant form. Efficiency and tolerability during a pilot study].
    Durand M; Bost F; Maynard M; Baud M; Cohard M; Zarski JP
    Presse Med; 1996 Mar; 25(9):459. PubMed ID: 8685199
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of hepatitis B virus replication by ganciclovir in kidney transplant patients.
    Garnier JL; Chossegros P; Daoud S; Chevallier P; Dubernard JM; Trepo C; Touraine JL
    Transplant Proc; 1997; 29(1-2):817. PubMed ID: 9123539
    [No Abstract]   [Full Text] [Related]  

  • 33. Design of new anti-viral agents for chronic hepatitis B virus infection.
    Locarnini S
    J Gastroenterol Hepatol; 1991; 6 Suppl 1():18-22. PubMed ID: 1751799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human viral hepatitis.
    Zuckerman AJ
    Pharmacol Ther; 1980; 10(1):1-13. PubMed ID: 6996001
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vidarabine phosphate in the treatment of active chronic hepatitis B. A confirmed hope].
    Ouzan D
    Rev Prat; 1992 Jun; 42(11):1383-6. PubMed ID: 1382310
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B].
    Taéron C
    Rev Infirm; 2009 Sep; (153):49-51. PubMed ID: 19771814
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
    Benhamou Y; Dohin E; Lunel-Fabiani F; Poynard T; Huraux JM; Katlama C; Opolon P; Gentilini M
    Lancet; 1995 Feb; 345(8946):396-7. PubMed ID: 7845151
    [No Abstract]   [Full Text] [Related]  

  • 38. Liver transplantation for hepatitis B.
    Samuel D; Bismuth H
    Gastroenterol Clin North Am; 1993 Jun; 22(2):271-83. PubMed ID: 8509171
    [No Abstract]   [Full Text] [Related]  

  • 39. Surrogate end-points for treatment trials of hepatitis B virus.
    Griffiths PD
    Rev Med Virol; 2010 Jul; 20(4):199-201. PubMed ID: 20586100
    [No Abstract]   [Full Text] [Related]  

  • 40. A cell culture assay for compounds which inhibit hepatitis B virus replication.
    Korba BE; Milman G
    Antiviral Res; 1991; 15(3):217-28. PubMed ID: 1716089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.